CCRM’s Post

View organization page for CCRM, graphic

23,921 followers

Season four of “Commercializing Living Therapies with CCRM” kicked off with Christopher P. Boone, PhD, Oracle, and Kenneth Harris, OmniaBio, discussing how artificial intelligence (AI) and robotics are shaping the biomanufacturing facility of the future. In this clip, Chris explains how AI’s data collection technologies help personalize treatments for patients. “One of the more fascinating things, and this is the world where I live, is just the literal access to all the different types of data that we have about the patient. Whether it be, certainly, the data that we capture in their electronic health record as they’re having these routine encounters with their providers, there’s also genetic/genomic data that exists, this environmental data that we capture, this lifestyle data that we particularly care about. All of these data sources feed into what it would take to make medicine much more personalized and ultimately start to get into what those patient preferences are. As Ken mentioned, with these 70+ therapies that are now on label, patients do, or should, feel a bit more empowered to select therapies where they’re willing to accept certain risks for certain benefits.” Listen wherever you stream podcasts, or at the following link: https://lnkd.in/daTWUkEF #artificialintelligence, #AI, #robotics #regenmed #cellandgenetherapies #podcast

To view or add a comment, sign in

Explore topics